Facultad de Ciencias Veterinarias Report issue

Academic/Hospital Phase 1

Organization Overview

First Clinical Trial
2016
NCT03192449
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2019

Timeline

NOW
  • Now

Alternative names

CIVETAN CONICET, Facultad de Ciencias Veterinarias, UNCPBA. Tandil | CIVETAN-Tandil, UNCPBA

Active Ingredients

Drugs in Phase 1 Trials (1)

albendazole (Albenza) (2 trials)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Helminthiasis (Phase 1)

Overview

  • Highest Phase: Phase 1
  • # of Trials: 2
  • # of Trial APIs: 1